Control of mRNA translation plays crucial roles in cell growth, survival, and tumorigenesis.[29] Aberrations in translational control frequently occur in human cancers, often through activating key signaling pathways, i.e., c‐Myc, PI3K‐mTOR, and Ras‐MAPK pathways, but also through ectopic expression of translation initiation factors.[8, 30] However, the direct impact of metabolic genes on protein translation is still poorly understood. This evidence concerns the gene MYC and cancer.